NEWS & AWARDS
ALL SYNAPSY'S NEWS
SEARCH SYNAPSY’S NEWS
JUMP TO A SPECIFIC MONTH
#NCCRWomen – Marie Schaer
17 September 2021
https://nccr-synapsy.ch/wp-content/uploads/2021/08/NCCRW_SCHAER_FINAL.movMeet Marie Schaer, a researcher working for the NCCR Synapsy at the University of Geneva. Her studies aims to understand the symptoms of autism, a developmental disorder associated with communication...
Read More
#NCCRWomen – Zoé Schilliger
16 September 2021
https://nccr-synapsy.ch/wp-content/uploads/2021/08/NCCRW_SCHILLIGER_FINAL.movMeet Zoé Schilliger, a doctoral student in psychiatric neuroscience at the University of Lausanne and CHUV. She is working on stress management during adolescence, more specifically how it can lead...
Read More
#NCCRWomen – Camilla Bellone
15 September 2021
https://nccr-synapsy.ch/wp-content/uploads/2021/08/NCCRW_BELLONE_FINAL.movMeet Camilla Bellone, Director of the NCCR Synapsy and neuroscientist working at the University of Geneva. She is studying how the brain controls social behavior.The #NCCRWomen campaign introduces you to...
Read More
#NCCRWomen – Silvia Monari
14 September 2021
https://nccr-synapsy.ch/wp-content/uploads/2021/08/NCCR_MONARI_FINAL.movMeet Silvia Monari, a medical doctor doing a PhD in neuroscience at EPFL. She is studying how stress can affect memory and sleep for the NCCR Synapsy.Meet Marie Schaer, a...
Read More
Autism: a spectrum on the path to segmentation
13 September 2021
A UNIGE study backed by Synapsy has shown that the basic states of the brain functions of young children with autism spectrum disorder have a signature that is specific to...
Read More
#NCCRWomen – Farnaz Delavari
13 September 2021
https://nccr-synapsy.ch/wp-content/uploads/2021/08/NCCR_DELAVARI_FINAL.movMeet Farnaz Delavari, a medical doctor doing a PhD in neuroscience at the University of Geneva. She is studying the brain mechanisms that lead to psychosis and anxiety for the...
Read More
Using video for the early detection of autism
6 September 2021
Using artificial intelligence, a Synapsy team from the UNIGE has developed a device for the early detection of autism spectrum disorder in children. Individuals affected by autism spectrum disorder often...
Read More
Managing attention deficit disorder by training the brain
7 July 2021
A Synapsy team from the UNIGE and the HUG has found that a special type of brain training based on the principle of ‘neurofeedback’ enables people with attention deficit disorder...
Read More
Protecting the intellectual abilities of people at risk for psychosis
1 June 2021
A Synapsy team based at UNIGE has found that a class of drugs can protect the development of intellectual abilities in people at risk of psychosis, if prescribed before adolescence....
Read More
Lactate reveals all about its antidepressant prowess
27 May 2021
Neuroscientists at Synapsy have identified one of the mechanisms behind the antidepressant effect of lactate, a molecule produced by the body during exercise. Its key features – lactate, NADH and...
Read More
8 Replies
Overcoming long-term trauma can be facilitated
21 May 2021
Older traumatic experiences are harder to get over compared to recent ones, and Synapsy scientists based at EPFL have started to understand why – at the level of brain circuits...
Read More
Is schizophrenia the cost of a poor brain optimisation?
23 March 2021
Patients with 22q11.2 deletion syndrome have a high risk of developing schizophrenia. According to a recent study by neuroscientists from Synapsy, the Swiss National Research Centre of Competences in Research...
Read More
Why making the right choice is difficult when you’re stressed
9 March 2021
Study by members of Synapsy, the Swiss National Centre of Competence in Research in psychiatric disorders, explains why we make poor decisions after stress even when motivated by the prospect...
Read More
Invitation for entries for the Research prize of the Swiss Brain League
9 March 2021
Every two years, the Swiss Brain League awards a prize of CHF 20,000 to a Swiss research group in recognition of its outstanding scientific contribution in the field of neurological...
Read More
Has the ideal target for treating anxiety been discovered?
11 February 2021
Synapsy’s neuroscientists based at EPFL have identified a cell molecule that can regulate anxiety and prevent depression. Located at the crossroads of multiple cellular mechanisms, this molecule reconciles the great...
Read More
Poor wiring in the centre of the brain leads to psychosis
9 February 2021
Psychosis is linked to abnormalities in brain development. A team from the Synapsy National Centre of Competences in Research has demonstrated that the regions of the brain involved in processing...
Read More
Best wishes for 2021
24 December 2020
The Management Team wishes You all the Best for the New Year!
Read More
From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders
17 December 2020
We spoke with Charles Finsterwald, PhD, Chief Scientific Officer and co-founder of the start-up Gliapharm about his career path and his decision to switch from fundamental research to application.An interest...
Read More
Lactate, a prospect for the treatment of depression
17 December 2020
According to WHO, more than 264 million people in the world suffer from depression, a disorder that has a major impact on all facets of the lives of those it...
Read More
Holography and cellular reprogramming in the quest for biomarkers
17 December 2020
Bipolar disorders affect some 2% of the population. Patients present a wide variety of clinical symptoms of which many can be especially handicapping. A new approach to find biomarkers, driven...
Read More
